BriaCell Therapeutics Corp.
BCTXL$0.7299▼ 10.98% 24h
$0.7299
+$0.4856(+198.77%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$1.38M
P/E ratio
—
EPS (diluted)
$-62.19
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
—
Net income
$-26.31M
Net margin
—
Gross margin
—
Dividends & financials
BriaCell Therapeutics Corp. (BCTXL) reported revenue of — and net income of $-26.31M, or $-62.19 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
